⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Parkin Molecular Glue Activators
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-07-09 — Cell-Type-Specific Calibration of Mitochondrial Ubiquitination in Stem Cell Fate Decisions.: 2025 mechanistic review positions Parkin molecular glue activators alongside USP30 inhibitors and ClpP PROTACs as tunable levers on mitochondrial ubiquitination, with cell-type-specific stem-cell effects proposed but unproven in outcome studies (review-level synthesis). [mechanism-plausible] (novelty: 3)
Open questions
Related
Contributing findings
Cell-Type-Specific Calibration of Mitochondrial Ubiquitination in Stem Cell Fate Decisions.
09-jul-2026
novelty 3
per-area 3
strengthens